Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry)


      The recently concluded Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) was a randomized clinical trial of percutaneous coronary intervention versus coronary bypass graft surgery among patients with medically refractory ischemia who were at high risk for coronary bypass graft surgery because of ≥1 risk factors that included severely reduced left ventricular (LV) function, defined as LV ejection fraction <35%. This study reports the outcome of patients with LV ejection fraction <35% in the randomized clinical trial and the physician-directed and patient choice registries of the AWESOME study.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Morrison D.A
        • Sethi G
        • Sacks J
        • Henderson W
        • Grover F
        • Sedlis S.P
        • Esposito R
        • Ramanathan K.B
        • Weiman D
        • Saucedo J
        • et al.
        Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass.
        J Am Coll Cardiol. 2001; 38: 143-149
        • Morrison D.A
        • Sethi G
        • Sacks J
        • Henderson W
        • Grover F
        • Sedlis S.P
        • Esposito R
        • Ramanathan K.B
        • Weiman D
        • Saucedo J
        • et al.
        A multi-center, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The VA AWESOME multicenter registry.
        J Am Coll Cardiol. 2002; 39: 266-273
        • Rumsfeld J.S
        • Magid D.J
        • Plomondon M.E
        • Sacks J
        • Henderson W
        • Hlatky M
        • Sethi G
        • Morrison D.A
        Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia.
        J Am Coll Cardiol. 2003; 41: 1732-1738
        • Elefteriades J.A
        • Tolis Jr., G
        • Levi E
        • Mills L.K
        • Zaret B.L
        Coronary artery bypass grafting in severe left ventricular dysfunction.
        J Am Coll Cardiol. 1993; 22: 1411-1417
        • Baker D.W
        • Jones R
        • Hodges J
        • Massie B.M
        • Konstam M.A
        • Rose E.A
        Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction.
        JAMA. 1994; 272: 1528-1534
        • Stahle E
        • Bergstrom R
        • Edlund B
        • Frostfeldt G
        • Lagerquist B
        • Sjogren I
        • Hansson H.E
        Influence of left ventricular function on survival after coronary artery bypass grafting.
        Ann Thorac Surg. 1997; 64: 437-444
        • Trachiotis G.D
        • Weintraub W.S
        • Johnston T.S
        • Jones E.L
        • Guyton R.A
        • Craver J.M
        Coronary artery bypass grafting in patients with advanced left ventricular dysfunction.
        Ann Thorac Surg. 1998; 66: 1632-1639
        • Ellis S.G
        • Cowley M.J
        • DiSciascio G
        • Deligonul U
        • Topol E.J
        • Bulle T.M
        • Vandormael M.G
        Determinants of 2-year outcome after coronary angioplasty in patients with multivessel disease on the basis of comprehensive preprocedural evaluation. Implications for patient selection. The Multivessel Angioplasty Prognosis Study Group.
        Circulation. 1991; 83: 1905-1914
        • Kohli R.S
        • DiSciascio G
        • Cowley M.J
        • Nath A
        • Goudreau E
        • Vetrovec G.W
        Coronary angioplasty in patients with severe left ventricular dysfunction.
        J Am Coll Cardiol. 1990; 16: 807-811
        • Eltchaninoff H
        • Franco I
        • Whitlow P.L
        Late results of coronary angioplasty in patients with left ventricular ejection fractions ≤40%.
        Am J Cardiol. 1994; 73: 1047-1052
        • Killip T
        • Passamani E
        • Davis K
        Coronary Artery Surgery Study (CASS).
        Circulation. 1985; 72: V102-V109
        • Sharma G.V
        • Deupree R.H
        • Khuri S.F
        • Parisi A.F
        • Luchi R.J
        • Scott S.M
        Coronary bypass surgery improves survival in high-risk unstable angina. Results of a Veterans Administration Cooperative study with an 8-year follow-up. Veterans Administration Unstable Angina Cooperative Study Group.
        Circulation. 1991; 84: III260-III267
        • Eagle K.A
        • Guyton R.A
        • Davidoff R
        • Ewy G.A
        • Fonger J
        • Gardner T.J
        • Gott J.P
        • Herrmann H.C
        • Marlow R.A
        • Nugent W.C
        • et al.
        ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery.
        J Am Coll Cardiol. 1999; 34: 1262-1347
      1. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). 2002. Available at: Accessed March 16, 2002

        • Keelan P.C
        • Johnston J.M
        • Koru-Sengul T
        • Detre K.M
        • Williams D.O
        • Slater J
        • Block P.C
        • Holmes Jr, D.R
        • Dynamic Registry Investigators
        Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions ≤40%, 41% to 49%, and ≥50% having percutaneous coronary revascularization.
        Am J Cardiol. 2003; 91: 1168-1172
        • Cannon C.P
        • Weintraub W.S
        • Demopoulos L.A
        • Vicari R
        • Frey M.J
        • Lakkis N
        • Neumann F.-J
        • Robertson D.H
        • DeLucca P.T
        • DiBattiste P.M
        • Gibson C.M
        • Braunwald E
        • the TACTICS–Thrombolysis in Myocardial Infarction 18 Investigators
        Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
        N Engl J Med. 2001; 344: 1879-1887
        • FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators
        Invasive compared with non-invasive treatment in unstable coronary artery disease.
        Lancet. 1999; 354: 708-715
        • The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
        Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
        N Engl J Med. 2001; 345: 494-502
        • Mehta S.R
        • Yusuf S
        • Peters R.J
        • Bertrand M.E
        • Lewis B.S
        • Natarajan M.K
        • Malmberg K
        • Rupprecht H
        • Zhao F
        • Chrolavicius S
        • Copland I
        • Fox K.A
        • Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators
        Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention.
        Lancet. 2001; 358: 527-533